{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:24Z","timestamp":1791316704332,"version":"4.3.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001168","name":"Cancer Council Queensland","doi-asserted-by":"publisher","award":["AACR 000000027"],"award-info":[{"award-number":["AACR 000000027"]}],"id":[{"id":"10.13039\/501100001168","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001168","name":"Cancer Council Queensland","doi-asserted-by":"publisher","award":["1147067"],"award-info":[{"award-number":["1147067"]}],"id":[{"id":"10.13039\/501100001168","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Futures Fund Genomics Health Futures Mission","award":["2009160"],"award-info":[{"award-number":["2009160"]}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"crossref","award":["1147067"],"award-info":[{"award-number":["1147067"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"DOI":"10.1186\/s13073-026-01624-y","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:25:32Z","timestamp":1773725132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities"],"prefix":"10.1186","volume":"18","author":[{"given":"Katia","family":"Nones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Lakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Dalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haarika","family":"Chittoory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaltin","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambros T.","family":"Koufariotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Bashirzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwa","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmy","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fairbairn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Steinfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma J.","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gibney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Pahoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan Tien","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Solujic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Twaddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Grainge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Gune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil R.","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"1","key":"1624_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):3.","journal-title":"Nat Rev Dis Primers"},{"key":"1624_CR2","doi-asserted-by":"publisher","unstructured":"Kim SY, Park HS, Chiang AC. Small cell lung cancer: a review. JAMA. 2025;333(21):1906\u201317 . https:\/\/doi.org\/10.1001\/jama.2025.0560.","DOI":"10.1001\/jama.2025.0560"},{"issue":"11","key":"1624_CR3","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","volume":"39","author":"JM Chan","year":"2021","unstructured":"Chan JM, Quintanal-Villalonga A, Gao VR, Xie Y, Allaj V, Chaudhary O, et al. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell. 2021;39(11):1479-96 e18.","journal-title":"Cancer Cell."},{"issue":"6","key":"1624_CR4","doi-asserted-by":"publisher","first-page":"e35770","DOI":"10.1002\/cncr.35770","volume":"131","author":"MD Shields","year":"2025","unstructured":"Shields MD, Chiang AC, Byers LA. Top advances of the year: small cell lung cancer. Cancer. 2025;131(6):e35770.","journal-title":"Cancer"},{"issue":"5","key":"1624_CR5","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.29098","volume":"121","author":"LA Byers","year":"2015","unstructured":"Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? Cancer. 2015;121(5):664\u201372.","journal-title":"Cancer"},{"issue":"7793","key":"1624_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"Consortium ITP-CAoWG","year":"2020","unstructured":"Consortium ITP-CAoWG. Pan-cancer analysis of whole genomes. Nature. 2020;578(7793):82\u201393.","journal-title":"Nature"},{"issue":"1","key":"1624_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2023.12.004","volume":"187","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhang J, Guo C, Wang M, Wang C, Yan Y, et al. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies. Cell. 2024;187(1):184-203 e28.","journal-title":"Cell"},{"issue":"7563","key":"1624_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524(7563):47\u201353.","journal-title":"Nature"},{"issue":"6","key":"1624_CR9","doi-asserted-by":"publisher","first-page":"101610","DOI":"10.1016\/j.xcrm.2024.101610","volume":"5","author":"P Desai","year":"2024","unstructured":"Desai P, Takahashi N, Kumar R, Nichols S, Malin J, Hunt A, et al. Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities. Cell Rep Med. 2024;5(6):101610.","journal-title":"Cell Rep Med"},{"issue":"2","key":"1624_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccell.2024.01.001","volume":"42","author":"S Heeke","year":"2024","unstructured":"Heeke S, Gay CM, Estecio MR, Tran H, Morris BB, Zhang B, et al. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes. Cancer Cell. 2024;42(2):225-37 e5.","journal-title":"Cancer Cell"},{"issue":"3","key":"1624_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","volume":"39","author":"CM Gay","year":"2021","unstructured":"Gay CM, Stewart CA, Park EM, Diao L, Groves SM, Heeke S, et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell. 2021;39(3):346-60 e7.","journal-title":"Cancer Cell"},{"issue":"3","key":"1624_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ccell.2024.01.010","volume":"42","author":"BY Nabet","year":"2024","unstructured":"Nabet BY, Hamidi H, Lee MC, Banchereau R, Morris S, Adler L, et al. Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade. Cancer Cell. 2024;42(3):429-43 e4.","journal-title":"Cancer Cell"},{"issue":"7","key":"1624_CR13","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1158\/2159-8290.CD-22-0620","volume":"13","author":"S Sivakumar","year":"2023","unstructured":"Sivakumar S, Moore JA, Montesion M, Sharaf R, Lin DI, Colon CI, et al. Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histologic transformation. Cancer Discov. 2023;13(7):1572\u201391.","journal-title":"Cancer Discov"},{"issue":"5","key":"1624_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","volume":"19","author":"CM Rudin","year":"2019","unstructured":"Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer. 2019;19(5):289\u201397.","journal-title":"Nat Rev Cancer"},{"key":"1624_CR15","doi-asserted-by":"publisher","unstructured":"Dolkar T, Gates C, Hao Z, Munker R. New developments in immunotherapy for SCLC. J Immunother Cancer. 2025;13(1):e009667. https:\/\/doi.org\/10.1136\/jitc-2024-009667.","DOI":"10.1136\/jitc-2024-009667"},{"issue":"4","key":"1624_CR16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1158\/1078-0432.CCR-23-1689","volume":"30","author":"L Paz-Ares","year":"2024","unstructured":"Paz-Ares L, Garassino MC, Chen Y, Reinmuth N, Hotta K, Poltoratskiy A, et al. Durvalumab +\/- Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden. Clin Cancer Res. 2024;30(4):824\u201335.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1624_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00432-023-05544-x","volume":"150","author":"L Zhu","year":"2024","unstructured":"Zhu L, Qin J. Predictive biomarkers for immunotherapy response in extensive-stage SCLC. J Cancer Res Clin Oncol. 2024;150(1):22.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5-6","key":"1624_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1101\/gad.349359.122","volume":"36","author":"KD Sutherland","year":"2022","unstructured":"Sutherland KD, Ireland AS, Oliver TG. Killing SCLC: insights into how to target a shapeshifting tumor. Genes Dev. 2022;36(5\u20136):241\u201358.","journal-title":"Genes Dev"},{"issue":"1","key":"1624_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-024-01953-9","volume":"23","author":"A Solta","year":"2024","unstructured":"Solta A, Ernhofer B, Boettiger K, Megyesfalvi Z, Heeke S, Hoda MA, et al. Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer. Mol Cancer. 2024;23(1):41.","journal-title":"Mol Cancer"},{"issue":"22","key":"1624_CR20","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMoa2307980","volume":"389","author":"MJ Ahn","year":"2023","unstructured":"Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, et al. Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med. 2023;389(22):2063\u201375.","journal-title":"N Engl J Med"},{"key":"1624_CR21","doi-asserted-by":"publisher","unstructured":"Fielding D, Lakis V, Dalley AJ, Chittoory H, Newell F, Koufariotis LT, et al. Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) samples from advanced non-small cell lung cancer for whole genome, whole exome and comprehensive panel sequencing. Cancers (Basel). 2024;16(4):785. https:\/\/doi.org\/10.3390\/cancers16040785.","DOI":"10.3390\/cancers16040785"},{"issue":"9","key":"1624_CR22","doi-asserted-by":"publisher","first-page":"e45835","DOI":"10.1371\/journal.pone.0045835","volume":"7","author":"S Song","year":"2012","unstructured":"Song S, Nones K, Miller D, Harliwong I, Kassahn KS, Pinese M, et al. Qpure: a tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles. PLoS One. 2012;7(9):e45835.","journal-title":"PLoS One"},{"key":"1624_CR23","doi-asserted-by":"crossref","unstructured":"Nones K, Lakis V, Dalley AJ, al e. Multi-omics reveals heterogeneity in advanced small cell lung cancers data set. GSE307029. Gene Expression Omnibus. 2026. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE307029.","DOI":"10.2139\/ssrn.5444499"},{"issue":"10","key":"1624_CR24","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363\u20139.","journal-title":"Bioinformatics"},{"issue":"3","key":"1624_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","volume":"30","author":"TJ Morris","year":"2014","unstructured":"Morris TJ, Butcher LM, Feber A, Teschendorff AE, Chakravarthy AR, Wojdacz TK, et al. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics. 2014;30(3):428\u201330.","journal-title":"Bioinformatics"},{"issue":"2","key":"1624_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","volume":"29","author":"AE Teschendorff","year":"2013","unstructured":"Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013;29(2):189\u201396.","journal-title":"Bioinformatics"},{"issue":"12","key":"1624_CR27","doi-asserted-by":"publisher","first-page":"e8274","DOI":"10.1371\/journal.pone.0008274","volume":"4","author":"AE Teschendorff","year":"2009","unstructured":"Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One. 2009;4(12):e8274.","journal-title":"PLoS One"},{"issue":"1","key":"1624_CR28","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1038\/s41467-018-05570-1","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy A, Furness A, Joshi K, Ghorani E, Ford K, Ward MJ, et al. Pan-cancer deconvolution of tumour composition using DNA methylation. Nat Commun. 2018;9(1):3220.","journal-title":"Nat Commun"},{"key":"1624_CR29","doi-asserted-by":"publisher","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. 2011;17(1);10\u20132. https:\/\/doi.org\/10.14806\/ej.17.1.200.","DOI":"10.14806\/ej.17.1.200"},{"issue":"1","key":"1624_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"key":"1624_CR31","doi-asserted-by":"crossref","unstructured":"Nones K, Lakis V, Dalley AJ, al e. SCLC WGS and RNASeq data sets for manuscript titled: \u201cMulti-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities\u201d. EGAS00001007832. European Genome-Phenome Archive; 2026. https:\/\/ega-archive.org\/studies\/EGAS00001007832.","DOI":"10.1186\/s13073-026-01624-y"},{"key":"1624_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"1624_CR33","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11(3):R25.","journal-title":"Genome Biol"},{"issue":"11","key":"1624_CR34","doi-asserted-by":"publisher","first-page":"e74380","DOI":"10.1371\/journal.pone.0074380","volume":"8","author":"KS Kassahn","year":"2013","unstructured":"Kassahn KS, Holmes O, Nones K, Patch AM, Miller DK, Christ AN, et al. Somatic point mutation calling in low cellularity tumors. PLoS One. 2013;8(11):e74380.","journal-title":"PLoS One"},{"issue":"9","key":"1624_CR35","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"},{"issue":"2","key":"1624_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, le Wang L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80\u201392.","journal-title":"Fly (Austin)"},{"key":"1624_CR37","doi-asserted-by":"publisher","first-page":"15 9 1","DOI":"10.1002\/cpbi.17","volume":"56","author":"KM Raine","year":"2016","unstructured":"Raine KM, Van Loo P, Wedge DC, Jones D, Menzies A, Butler AP, et al. AscatNgs: identifying somatically acquired copy-number alterations from whole-genome sequencing data. Curr Protoc Bioinform. 2016;56:15 9 1-1597.","journal-title":"Curr Protoc Bioinform"},{"issue":"4","key":"1624_CR38","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.","journal-title":"Genome Biol"},{"issue":"8028","key":"1624_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-024-07747-9","volume":"633","author":"AJ Cornish","year":"2024","unstructured":"Cornish AJ, Gruber AJ, Kinnersley B, Chubb D, Frangou A, Caravagna G, et al. The genomic landscape of 2,023 colorectal cancers. Nature. 2024;633(8028):127\u201336.","journal-title":"Nature"},{"issue":"7","key":"1624_CR40","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","volume":"30","author":"B Niu","year":"2014","unstructured":"Niu B, Ye K, Zhang Q, Lu C, Xie M, McLellan MD, et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinformatics. 2014;30(7):1015\u20136.","journal-title":"Bioinformatics"},{"issue":"1","key":"1624_CR41","doi-asserted-by":"publisher","first-page":"vbac005","DOI":"10.1093\/bioadv\/vbac005","volume":"2","author":"O Holmes","year":"2022","unstructured":"Holmes O, Nones K, Tang YH, Loffler KA, Lee M, Patch AM, et al. Qmotif: determination of telomere content from whole-genome sequence data. Bioinform Adv. 2022;2(1):vbac005.","journal-title":"Bioinform Adv"},{"key":"1624_CR42","doi-asserted-by":"publisher","unstructured":"Luebeck J, Huang E, Kim F, Liefeld T, Dameracharla B, Ahuja R, et al. AmpliconSuite: an end-to-end workflow for analyzing focal amplifications in cancer genomes. bioRxiv. 2024;2024.05.06.592768. https:\/\/doi.org\/10.1101\/2024.05.06.592768.","DOI":"10.1101\/2024.05.06.592768"},{"issue":"1","key":"1624_CR43","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41467-018-08200-y","volume":"10","author":"V Deshpande","year":"2019","unstructured":"Deshpande V, Luebeck J, Nguyen ND, Bakhtiari M, Turner KM, Schwab R, et al. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat Commun. 2019;10(1):392.","journal-title":"Nat Commun"},{"issue":"5","key":"1624_CR44","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gcc.22918","volume":"60","author":"D H\u00fcbschmann","year":"2021","unstructured":"H\u00fcbschmann D, Jopp-Saile L, Andresen C, Kr\u00e4mer S, Gu Z, Heilig CE, et al. Analysis of mutational signatures with yet another package for signature analysis. Genes Chromosomes Cancer. 2021;60(5):314\u201331.","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"1624_CR45","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41467-018-03099-x","volume":"9","author":"J George","year":"2018","unstructured":"George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, et al. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nat Commun. 2018;9(1):1048.","journal-title":"Nat Commun"},{"issue":"5","key":"1624_CR46","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ng.127","volume":"40","author":"I Ben-Porath","year":"2008","unstructured":"Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40(5):499\u2013507.","journal-title":"Nat Genet"},{"issue":"9","key":"1624_CR47","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jtho.2023.05.008","volume":"18","author":"CM Rudin","year":"2023","unstructured":"Rudin CM, Balli D, Lai WV, Richards AL, Nguyen E, Egger JV, et al. Clinical benefit from immunotherapy in patients with SCLC is associated with tumor capacity for antigen presentation. J Thorac Oncol. 2023;18(9):1222\u201332.","journal-title":"J Thorac Oncol"},{"issue":"1-2","key":"1624_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160(1\u20132):48\u201361.","journal-title":"Cell"},{"issue":"1","key":"1624_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.21037\/tlcr.2018.02.02","volume":"7","author":"W Zhang","year":"2018","unstructured":"Zhang W, Girard L, Zhang YA, Haruki T, Papari-Zareei M, Stastny V, et al. Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes. Transl Lung Cancer Res. 2018;7(1):32\u201349.","journal-title":"Transl Lung Cancer Res"},{"issue":"12","key":"1624_CR50","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.trecan.2018.10.003","volume":"4","author":"O Lancho","year":"2018","unstructured":"Lancho O, Herranz D. The MYC enhancer-ome: long-range transcriptional regulation of MYC in cancer. Trends Cancer. 2018;4(12):810\u201322.","journal-title":"Trends Cancer"},{"issue":"8005","key":"1624_CR51","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41586-024-07177-7","volume":"627","author":"J George","year":"2024","unstructured":"George J, Maas L, Abedpour N, Cartolano M, Kaiser L, Fischer RN, et al. Evolutionary trajectories of small cell lung cancer under therapy. Nature. 2024;627(8005):880\u20139.","journal-title":"Nature"},{"issue":"1","key":"1624_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12943-024-02014-x","volume":"23","author":"M Xie","year":"2024","unstructured":"Xie M, Vuko M, Rodriguez-Canales J, Zimmermann J, Schick M, O\u2019Brien C, et al. Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study. Mol Cancer. 2024;23(1):115.","journal-title":"Mol Cancer"},{"issue":"3","key":"1624_CR53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jtho.2024.10.021","volume":"20","author":"NA Karim","year":"2025","unstructured":"Karim NA, Miao J, Reckamp KL, Gay CM, Byers LA, Zhao YQ, et al. Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929. J Thorac Oncol. 2025;20(3):383\u201394.","journal-title":"J Thorac Oncol"},{"key":"1624_CR54","doi-asserted-by":"publisher","unstructured":"Ma Y, Yang Y, Huang Y, Fang W, Xue J, Meng X, et al. A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1\/1b trial. Nat Med. 2025;31:1949\u201357. https:\/\/doi.org\/10.1038\/s41591-025-03600-2.","DOI":"10.1038\/s41591-025-03600-2"},{"issue":"6","key":"1624_CR55","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1158\/1535-7163.MCT-21-0851","volume":"21","author":"WR Wiedemeyer","year":"2022","unstructured":"Wiedemeyer WR, Gavrilyuk J, Schammel A, Zhao X, Sarvaiya H, Pysz M, et al. ABBV-011, A Novel, Calicheamicin-Based Antibody-Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors. Mol Cancer Ther. 2022;21(6):986\u201398.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"1624_CR56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jtho.2024.12.028","volume":"20","author":"A Dowlati","year":"2025","unstructured":"Dowlati A, Chiang AC, Cervantes A, Babu S, Hamilton E, Wong SF, et al. Phase 2 open-label study of sacituzumab govitecan as second-line therapy in patients with extensive-stage SCLC: results from TROPiCS-03. J Thorac Oncol. 2025;20(6):799\u2013808.","journal-title":"J Thorac Oncol"},{"key":"1624_CR57","doi-asserted-by":"crossref","unstructured":"Morgensztern D, Ready NE, Johnson ML, Dowlati A, Choudhury NJ, Carbone DP, et al. First-in-human study of ABBV-011, a seizure-related homolog protein 6 (SEZ6)-targeting antibody-drug conjugate, in patients with small cell lung cancer. J Clin Oncol. 2023;41(16).","DOI":"10.1200\/JCO.2023.41.16_suppl.3002"},{"issue":"2","key":"1624_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1158\/1078-0432.CCR-16-1040","volume":"23","author":"BH Lok","year":"2017","unstructured":"Lok BH, Gardner EE, Schneeberger VE, Ni A, Desmeules P, Rekhtman N, et al. PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. Clin Cancer Res. 2017;23(2):523\u201335.","journal-title":"Clin Cancer Res"},{"key":"1624_CR59","doi-asserted-by":"publisher","first-page":"1504139","DOI":"10.3389\/fonc.2024.1504139","volume":"14","author":"J Ding","year":"2024","unstructured":"Ding J, Yeong C. Advances in DLL3-targeted therapies for small cell lung cancer: challenges, opportunities, and future directions. Front Oncol. 2024;14:1504139.","journal-title":"Front Oncol"},{"issue":"3","key":"1624_CR60","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/1759-7714.14249","volume":"13","author":"C Hu","year":"2022","unstructured":"Hu C, Dong J, Liu L, Liu J, Sun X, Teng F, et al. ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China. Thorac Cancer. 2022;13(3):338\u201345.","journal-title":"Thorac Cancer"},{"issue":"1","key":"1624_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jtho.2021.08.763","volume":"17","author":"S Qu","year":"2022","unstructured":"Qu S, Fetsch P, Thomas A, Pommier Y, Schrump DS, Miettinen MM, et al. Molecular subtypes of primary SCLC tumors and their associations with neuroendocrine and therapeutic markers. J Thorac Oncol. 2022;17(1):141\u201353.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"1624_CR62","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1038\/s41598-024-52687-z","volume":"14","author":"Y Lu","year":"2024","unstructured":"Lu Y, Li H, Zhao P, Tian L, Liu Y, Sun X, et al. Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer. Sci Rep. 2024;14(1):2884.","journal-title":"Sci Rep"},{"issue":"1","key":"1624_CR63","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s10020-024-01051-y","volume":"30","author":"Y Lu","year":"2024","unstructured":"Lu Y, Li H, Zhao P, Wang X, Shao W, Liu Y, et al. Crosstalk between cancer-associated fibroblasts and non-neuroendocrine tumor cells in small cell lung cancer involves in glycolysis and antigen-presenting features. Mol Med. 2024;30(1):274.","journal-title":"Mol Med"},{"issue":"3","key":"1624_CR64","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ccell.2025.01.012","volume":"43","author":"H Chen","year":"2025","unstructured":"Chen H, Deng C, Gao J, Wang J, Fu F, Wang Y, et al. Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer. Cancer Cell. 2025;43(3):519-36 e5.","journal-title":"Cancer Cell"},{"issue":"6","key":"1624_CR65","doi-asserted-by":"publisher","first-page":"748","DOI":"10.21037\/tlcr.2019.10.09","volume":"8","author":"Y Sun","year":"2019","unstructured":"Sun Y, Zhai C, Chen X, Dong Z, Hou L, Zhou C, et al. Characterization of PD-L1 protein expression and CD8(+) tumor-infiltrating lymphocyte density, and their associations with clinical outcome in small-cell lung cancer. Transl Lung Cancer Res. 2019;8(6):748\u201359.","journal-title":"Transl Lung Cancer Res"},{"key":"1624_CR66","doi-asserted-by":"publisher","first-page":"108033","DOI":"10.1016\/j.lungcan.2024.108033","volume":"198","author":"Z Yu","year":"2024","unstructured":"Yu Z, Zou J, Xu F. The molecular subtypes of small cell lung cancer defined by key transcription factors and their clinical significance. Lung Cancer. 2024;198:108033.","journal-title":"Lung Cancer"},{"issue":"5","key":"1624_CR67","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.celrep.2016.06.081","volume":"16","author":"MD Borromeo","year":"2016","unstructured":"Borromeo MD, Savage TK, Kollipara RK, He M, Augustyn A, Osborne JK, et al. ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs. Cell Rep. 2016;16(5):1259\u201372.","journal-title":"Cell Rep"},{"key":"1624_CR68","doi-asserted-by":"publisher","first-page":"107418","DOI":"10.1016\/j.lungcan.2023.107418","volume":"186","author":"SV Liu","year":"2023","unstructured":"Liu SV, Mok TSK, Nabet BY, Mansfield AS, De Boer R, Losonczy G, et al. Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide. Lung Cancer. 2023;186:107418.","journal-title":"Lung Cancer"},{"issue":"9","key":"1624_CR69","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s00432-021-03784-3","volume":"148","author":"S Omori","year":"2022","unstructured":"Omori S, Muramatsu K, Kawata T, Miyawaki E, Miyawaki T, Mamesaya N, et al. Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments. J Cancer Res Clin Oncol. 2022;148(9):2455\u201363.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"29","key":"1624_CR70","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1200\/JCO.23.00059","volume":"41","author":"T Shimizu","year":"2023","unstructured":"Shimizu T, Sands J, Yoh K, Spira A, Garon EB, Kitazono S, et al. First-in-human, phase I dose-escalation and dose-expansion study of trophoblast cell-surface antigen 2-directed antibody-drug conjugate datopotamab deruxtecan in non-small-cell lung cancer: TROPION-PanTumor01. J Clin Oncol. 2023;41(29):4678\u201387.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1624_CR71","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s43018-025-00996-1","volume":"6","author":"A Thomas","year":"2025","unstructured":"Thomas A, Mohindroo C, Giaccone G. Advancing therapeutics in small-cell lung cancer. Nat Cancer. 2025;6(6):938\u201353.","journal-title":"Nat Cancer"},{"key":"1624_CR72","unstructured":"Lakis V, Nones K, Dalley AJ, al e. Muilti-Omics-SCLC. GitHub. 2026. https:\/\/github.com\/NonesLab\/Multi-Omics-SCLC\/."}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-026-01624-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T02:02:34Z","timestamp":1776996154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13073-026-01624-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1624"],"URL":"https:\/\/doi.org\/10.1186\/s13073-026-01624-y","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Royal Brisbane & Women\u2019s Hospital human research ethics committee (HREC\/17\/QRBW\/301\u2014ERM 35887) and ratified by other hospitals and research organizations (University of Queensland\u20142018\/HE001615; QIMR Berghofer\u2014P2404). Study was conducted in accordance with guidelines of the Helsinki Declaration and NHMRC- The National Statement on Ethical Conduct in Human Research. Patients have consented for their data to be used in research studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Conflicts of interest: John Pearson and Nicola Waddell are founders of genomiQa, a spin out company from QIMR Berghofer. The remaining authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}